Dr Martens Maintains Annual Outlook on Strong US Wholesale Demand

British footwear brand Dr Martens has confirmed its annual financial targets, supported by strengthening wholesale demand in the United States. The company noted better-than-expected performance in its wholesale channel, particularly in the US market, which has emerged as a key factor supporting overall sales expectations. Dr Martens also reported steady growth in retail sales recently. The company expects strong demand in both its direct-to-consumer channel and wholesale distribution network to help achieve its annual revenue and profit margin targets. It emphasized that wholesale orders from the US market have made a positive contribution to overall performance. Analysts view the revival in Dr Martens' US wholesale demand as critical to the brand's global growth strategy. The company is also seeing balanced growth in European and Asian markets. However, risks such as macroeconomic uncertainties and currency fluctuations remain. Dr Martens expects this positive momentum to continue in the second half of the fiscal year. Management aims to enhance profitability through cost control and operational efficiency measures. While investors have welcomed the company's maintained annual outlook, a short-term recovery in share prices is anticipated. This is not investment advice.